Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.04 USD | +5.78% | +4.00% | -6.31% |
31/05 | Organovo Holdings, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
15/04 | Organovo's fatty liver disease drug meets main goal in mid-stage study | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.31% | 12.74M | |
+48.64% | 54.63B | |
-6.44% | 39.92B | |
+37.07% | 38.82B | |
+14.28% | 26.86B | |
-11.17% | 26.22B | |
-21.40% | 18.78B | |
+25.64% | 12.21B | |
+0.96% | 12.16B | |
+27.04% | 11.94B |
- Stock Market
- Equities
- ONVO Stock
- News Organovo Holdings, Inc.
- Organovo Holdings, Inc. Announces Resignation of Sharon Presnell as Chief Scientific Officer, Effective December 5, 2018